XRay Vision: A phase 3 study of xevinapant plus radiotherapy (RT) for high-risk, cisplatin-ineligible patients with resected, locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

被引：0
|
作者：
Ferris, Robert L.
Mehanna, Hisham Mohamed
Schoenfeld, Jonathan Daniel
Tahara, Makoto
Yom, Sue S.
Haddad, Robert I.
Koenig, Andre
Salmio, Satu Maaria
Bajars, Marcis
Le Tourneau, Christophe
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Univ Birmingham, Birmingham, England
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[5] UCSF, Med Ctr Mt Zion, San Francisco, CA USA
[6] Dana Farber Canc Inst, Ctr Head & Neck Oncol, Boston, MA USA
[7] Healthcare Business Merck KGaA, Darmstadt, Germany
[8] Healthcare Business Merck KGaA, Darmstadt, Germany
[9] Inst Curie, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS6101
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Multicentre phase II study of docetaxel (D) and cisplatin (C) as induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Lorenzo, JRM
    Rodríguez, MR
    Constenla, M
    Davila, A
    Fernández-Piera, M
    ANNALS OF ONCOLOGY, 2000, 11 : 92 - 92
  • [42] Preliminary analysis of ECOG 3303: Concurrent radiation (RT), cisplatin (DDP) and cetuximab (C) in unresectable, locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)
    Langer, C. J.
    Lee, J. W.
    Patel, U. A.
    Shin, D. M.
    Argiris, A. E.
    Quon, H.
    Ridge, J. A.
    Forastiere, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Phase II trial of radiotherapy (RT) with concurrent cisplatin (C) plus panitumumab (pmAb) for patients (pts) with high-risk, resected head and neck cancer (HNC).
    Ferris, Robert L.
    Schmitt, Nicole Cherie
    Heron, Dwight Earl
    Johnson, Jonas Talmadge
    Kim, Seungwon
    Duvvuri, Umamaheswar
    Clump, David Andrew
    Grandis, Jennifer
    Bauman, Julie E.
    Gooding, William E.
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Caponigro, F.
    Franchin, G.
    Rav, V.
    Silvestro, G.
    Morrica, B.
    Romano, C.
    Minatel, E.
    Pepe, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 313 - 313
  • [45] Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy
    Sheth, S.
    Bauman, J. R.
    Deal, A.
    Chera, B.
    Shen, C.
    Galloway, T.
    Hackman, T.
    Blumberg, J.
    Yarbrough, W.
    Weissler, M.
    Hilliard, C.
    Mehra, R.
    Grilley-Olson, J.
    Weiss, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] The IAP antagonist xevinapant, in combination with high-dose cisplatin chemoradiotherapy, induces NF-kB and apoptotic pathway biomarkers in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
    Piggott, Luke
    Gavillet, Bruno
    Brichory, Franck
    Gollmer, Kathrin
    Bouisset, Florilene
    Vuagniaux, Gregoire
    CANCER RESEARCH, 2022, 82 (12)
  • [47] A phase 1, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    El-Hariry, I.
    Harrington, K.
    Bourhis, J.
    Holford, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S30 - S30
  • [48] Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
    Le Tourneau, C.
    Calugaru, V.
    Takacsi-Nagy, Z.
    Liem, X.
    Papai, Z.
    Fijuth, J.
    Garcia, V. Moreno
    Garcia, I. Brana
    Salas, S.
    Poissonnet, G.
    Calvo, E.
    Doger, B.
    Choussy, O.
    Mirabel, X.
    Krhili, S.
    Bernois, K.
    Fakhry, N.
    Kam, S. Wong Hee
    Borcoman, E.
    Hoffmann, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E392 - E392
  • [49] Concomitant low-dose cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN): Analysis of survival and toxicity.
    Lau, H
    Yee, D
    Mackinnon, J
    Brar, S
    Hao, D
    Gluck, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 501S - 501S
  • [50] Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results on efficacy and correlative analysis
    Vathiotis, I.
    Johnson, J. M.
    Harshyne, L.
    Luginbuhl, A.
    Curry, J. M.
    Cognetti, D.
    Axelrod, R.
    Bar-Ad, V.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S850 - S850
12345